Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
0 hedge funds and large institutions have $0 invested in Ampio Pharmaceuticals Inc. in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $67 → $0 (-$67)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCMW
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
|
-$67 |
AMPE Hedge Fund Activity: Q2 2026 in Review
0 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2026, worth a combined $0 — down 100% from $67 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AMPE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Cypress Capital Management (Wyoming), exiting entirely with an estimated $67 sold.
- 0 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2026, down from 1 in Q1 2026.
- Funds reported $0 of Ampio Pharmaceuticals Inc. stock for Q2 2026, down 100% quarter-over-quarter.
- 0 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2026 and 1 closed out, a net change of -1 holder.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2026 was Cypress Capital Management (Wyoming), an estimated $67 sold.
Based on aggregated 13F filings for Q2 2026.